Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Clinical trial NCT07115004 · RECRUITING
Trial details
- NCT number
- NCT07115004
- Sponsor
- Vega Therapeutics, Inc
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-15
- Primary completion
- 2028-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.